Module 3: Respiratory Disorders Flashcards
The asthma updates’ most highly pediatric-relevant recommendations involve three treatment options: (1) intermittent ICS dosing with -A- for quick-relief therapy, (2) -B- and reliever therapy, and (3) -C-
A. as-needed short-acting b2-agonist (SABA)
B. single maintenance (SMART)
C. add-on LAMA therapy
In children 0 to 4 years with intermittent asthma, clinicians may now conditionally recommend a -1- course of -2- with as-needed SABA at the start of a -3- for children who have had -4- of similar wheezing or >1 episodes in the past year and who are -5-.
- short (7–10 days)
- daily ICS
- viral URI
- > 2 lifetime episodes
- asymptomatic between episodes
In those >11 years with -1-, clinicians and families may jointly decide to use -2- -3- instead of daily ICS with as-needed SABA.
- mild persistent asthma
- intermittent as-needed concomitant
- ICS with SABA
For patients >3 years with mild to moderate persistent asthma who are likely adherent with daily ICS alone, a short-term increase in the ICS dose (eg, doubling, tripling, or quadrupling the daily dose) -1-. It -2- for patients whose adherence is less certain.
- is not recommended
2. may be considered
SMART is treatment with -1- and a specific LABA (-2-) for both -3- therapy
- ICS
- formoterol
- daily and rescue
Formoterol is the LABA of choice for SMART because it has a -1- onset of action and can be used -2- daily.
- rapid
2. more than twice
Individuals whose asthma is uncontrolled on daily ICS-LABA maintenance therapy should receive the preferred … before moving to a higher-step level of therapy
SMART
-1- or -2- (in liquid or tablet form) reduces the -3- allergic response associated with asthma.
- Subcutaneous immunotherapy (SCIT)
- sublingual immunotherapy (SLIT)
- immunoglobulin E–mediated
In children ages -1- with -2-, the Expert Panel recommends -3- to predict the future development of asthma.
- 0–4 years
- recurrent wheezing
- against FeNO measurement
Asthma is characterized by variable and recurring symptoms of: -1-, -2-, and -3-
- Airflow obstruction
- Bronchial Hyperresponsiveness
- Underlying inflammation
What is the most common trigger for an asthma exacerbation in a 4 year old child? A. Upper respiratory infection B. Exercise C. Cold air D. Cigarette smoke E. Allergic rhinitis
A
Pathophysiology of asthma is a cycle of -1-, -2- in response to triggers, -3-, and -4-
- Airway remodeling
- Hyperresponsiveness and inflammation
- Obstruction
- Partial recovery (compared to full recovery in healthy lungs)
Difficulty breathing/SOB, chronic cough, cough after exercise, chest pain, wheezing, and/or night cough
Symptoms of childhood asthma
Early phase of asthmatic response is characterized by -1- and responsive to -2-. Begins in -3- in response to a trigger and abates in -4- to 2 hours. Common triggers include animal dander, pollen, mold, dust, -5-, exercise
- Inflammation and bronchoconstriction
- Albuterol
- 10-20 min
- 30 min
- cold air
Late phase asthmatic response is characterised by -1-. Caused by an ongoing production of the -2-. Usually begins in -3- after initial attack, reaches a maximum in -4- and disappears within -5-
- obstruction of airflow
- mediators of inflammation and bronchoconstriction
- 4-12 hrs
- 6-12 hrs
- 12-24 hrs
Late phase asthmatic response: May be more severe and occur -1-. -2- are not effective for this late phase, but -3- are.
- at night
- Bronchodilators
- anti-inflammatory medications, like steroids,
A 3 year old child with multiple episodes of wheezing, which of the following is a major risk factor for the future development of asthma? • A. History of bronchiolitis • B. Atopic dermatitis • C. History of food allergy • D. 10% peripheral eosinophilia • E. Uncle with asthma
B
Asthma Diagnosis (0-4): Major Criteria: -1- history of -2-; physician diagnosis of -3-; Minor Criteria: physician diagnosed -4-, wheezing unrelated to colds, -5- >3%
- parental
- asthma
- atopic dermatitis
- allergic rhinitis
- Eosinophils
What is considered the “gold standard” for diagnosing asthma in children 6 years and up?
Spirometry (PFT)
Major differential for asthma in the newborn/early infant
bronchopulmonary dysplasia
Top 3 differentials for asthma
Tracheo-bronchomalacia, GER, CF
Four Components of Care: 1. Assessment and Monitoring
Four major factors used for classification of Asthma
Age
Phenotypes
Severity
Control
Four Components of Care: 1. Assessment and Monitoring
Guiding Asthma Principle I: Reduce -1-
• -2- chronic and troublesome symptoms
• Minimize the need to use -3- of asthma symptoms to ≤two days/week, maintain (near) normal pulmonary function
• Maintain normal -4- levels
• Prevent -5-
- impairment
- Prevent
- SABA for relief
- activity
- reduced lung growth
Four Components of Care: 1. Assessment and Monitoring
Guiding Asthma Principle II: Reduce -1-
• Prevent recurrent -2-
• Provide optimal -3- or -4-
• Step-down therapy: -5- to maintain control
- Risk
- exacerbations
- pharmacotherapy with minimal
- no adverse effects
- minimum medication necessary